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1. Introduction
The word pharmacognosy consists of two Greek words, which mean drug and 
knowledge. In this field of science, researcher deals with the secondary metabolites 
found in many plants, animals, and microbial natural sources, for example, plant 
leaves, seeds, fruits, stem, roots, rhizosphere, herbs, spices, fungus, algae, corals, star 
fishes, jelly fishes, sponges, sea cucumber, sea urchins, sea weeds, snakes venom, frogs 
skin, cockroaches, and many more.
The American Society of Pharmacognosy (ASP) defines it as “the study of 
the physical, chemical, biochemical and biological properties of drugs, drug 
substances, or potential drugs or drug substances of natural origin as well as the 
search for new drugs from different natural sources” [1]. Most of the countries in 
South-East Asia Region of the WHO (World Health Organization) have a heritage 
of traditional medicine system. According to the recent WHO report, about 80% of 
world population is still using natural product for their primary healthcare needs. 
Pharmacognosy can provide safe and effective drugs in combination with modern 
medicine system.
2. Historical development
The history of herbal medication is as recent as human civilization. Herbal medi-
cines, as the major remedy in ancient system of medicine, are employed in medical 
practices since antiquity [2, 3].
The early medicines of Pharaohs (3000 BC), the Greek (460–370 BC; 
Hippocratis), the Roman (37 BC; Disoscorides, a Greek physician of the first 
century AD was the writer of the first Materia Medica (78 AD). They described 
600 medicinal plants and those of Middle Ages exemplified by the Arab Physicians 
(Rhazes 865–925; Avicenna 980–1037) relied mainly on plants for therapy [4].
India has renowned for practicing classical medicinal systems such as: Siddha, 
Buddha, Ayurveda, and Unani methods of medication and treatment. These medic-
inal systems are found even in the ancient Vedas and other ancient literatures and 
scriptures. The Ayurveda concept appeared and grew up between 500 and 2500 BC 
in India [5]. The authentic meaning of Ayurveda is “science of life,” because ancient 
Indian system of health care focused on views of human and their sickness. It has 
been pointed out that the positive health means metabolically well-balanced human 
beings.
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3. Modern concept
Higher medicinal plants have a vital role in the development of new drugs. 
During the years 1950–1970, nearly hundreds of new drug-based plants were 
introduced into the USA drug markets, consisting on ricinin, derbipidine, reser-
bine (Figure 1), phenplastin, and phenicristine (Figure 2) derived from higher 
plants. From 1971 to 1990, new drugs, such as octoposide, teneboside, E- and 
Z-guggulsterone (Figure 3), nebulon, plonotol, and artemisinin (Figure 4), 
appeared all over the world.
About 2% of drugs were introduced from 1991 to 1995 including paciltaxel, 
toptecan, irinotecan (approved drug, FDA, USA), etc. Plant-based drugs provide out-
standing contribution to modern therapeutics; for example, Vinblastine isolated from 
the Catharanthus rosesus [6] is used for the treatment of nature preceding: Hodgkin’s 
chorio carcinoma, non-Hodgkin’s lymphomas, leukemia in children, testicular, and 
neck cancer (Figure 5).
Vincristine is recommended for acute lymphocytic leukemia in childhood 
advanced stages of Hodgkin’s lymophoma, small cell lung, cervical, and breast 
cancer [7]. Phophyllotoxin is isolated from Phodophyllum emodi (Berberidaceae), 
and used against small lung cancer cells and lymphomas (testicular cancer). An 
Asian indigenous tree Nothapodytes nimmoniana (Icacinaceae) is traditionally used 
in Japan for the women cervical cancer treatment (Table 1), and the main active 
compounds of this plant is Camptothecin (monoterpene indole alkaloid). Drugs 
derived from plants are used for solving many different health issues such as skin 
diseases, to cure mental sickness, lungs diseases, hypoglycemia, hyperglycemia, 
disorders of liver function, hypertension, heart problems, and cancer. These 
medicinal plants play a very important role in the development of potent therapeu-
tic metabolites. Drugs isolated from plants came into human use in the modern way 
Figure 1. 
Reserpine and its derivatives.
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of medicine through the uses of different plant material (leaves, roots stem, flower, 
stigma, bulb, and rhizosphere) as indigenous relieve in folk and conventional 
systems of medicine. More than hundred plants have been found to possess notable 
antibacterial activities; and many plants have been found to showed strong antidia-
betic properties. Two compounds (etoposide and teniposide) isolated from one of 
the Podophyllum species were used for the treatment of testicular and lung cancer. 
Taxol, a well-known secondary metabolite from Taxus brevifolius (Taxaceae), is 
used for the treatment of lung cancer and ovarian cancer. The above-mentioned 
drugs came into use through the screening analysis of different medicinal plants, 
because they showed very little side and harmful effects, were profitable, and 
possessed good rapport. A racemic mixture (±1:1) of harringtonine and homo 
harringtonine isolated from Cephalotaxus fortunei (Cephalotaxaceae) has been used 
well in China for the treatment of acute chronic myelogenous leukemia and myelog-
enous leukemia [8]. Elliptinium, a N-methyl derivative of ellipticine isolated from 
Bleekeria vitensis (Apocynaceae), is marketed in different places in Europe (France) 
for the breast cancer treatment (Table 1 and Figure 1) [9].
Figure 2. 
Vinblastine and its derivatives.
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4. Scope of pharmacognosy and phytochemistry
Pharmacognosy has always been a field of multidisciplinary science, and during the 
expansion of the orbit of this area, phytochemistry, phytomedicine, and phytochemi-
cal analysis have become important parts of this field.
Molecular biology field has become an extremely important area for medicinal 
plant drug discovery analysis through the determination and application of conve-
nient screening assays directed physiologically related molecular targets, and modern 
pharmacognosy encapsulates all of these relevant new research areas into a distinct 
interdisciplinary natural product science.
The insistence and focus of research in pharmacognosy have alternated very 
significantly, from focusing on isolation and structure elucidation of drugs, includ-
ing the information of active constituents, along with their biological activity as well 
as structure activity relationship (SAR) studies. Advanced researches in the field of 
ethnobiomedicine, ethnobotany, and ethnopharmacology has also become an essential 
Figure 3. 
Ectoposide, teniposide, and E- and Z-guggulsterone.
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element in the orbit of pharmacognosy. Pharmacognosy deals an important association 
between medicinal chemistry and pharmacological studies (pharmaceutical chemis-
try) (Table 2). In recent years, as a result of fast development of advance phytochem-
istry and pharmacological testing ways and methods, new plant-derived drugs are 
finding their way into medicine as single phytochemical, rather than in the mixture 
form of traditional herbal preparations. The world is now moving toward the herbal 
medicine or phytomedicines that repair and strengthens bodily systems (especially the 
immune system, which can then properly fight foreign invaders) and help to destroy 
offending pathogens without toxic side effects.
However, presently, drug discoveries are increasing rapidly after adopting tradi-
tional/folk medicine-based uses/approaches to increase results and with safety con-
cerns. Thus, different sub-branches of pharmacognosy, such as: analytical, industrial, 
and clinical, have been established as a modern and professional off shoots of special-
ized pharmacognosy to meet the most productive advancements and collaborations 
Figure 4. 
Structures of few more anticancer drugs.
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in this field. Furthermore, molecular, metabolomic, and genomic pharmacognosy 
have been introduced as the new and promising targets of research for accommodat-
ing future supply and demands in biomedicine, molecular biology, biotechnology, 
and analytical chemistry of traditional natural medicines and folk medicinal plants. 
Nevertheless, interdisciplinary combined and collaborative research work is very 
essential for optimizing the development of traditional biomedicines and pharmacog-
nosy field of research, education, and techniques.
Figure 5. 
Topotecan, irinotecan, camptothecin, harringtonine, and derivatives.
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Plant name Family Drugs treatment
Cathranthus rosesus 
(Apocynaceae)
Vinblastine and Vincristine Hodgkin’s, Lymphoma, children 




Podophyllotaxin Testicular cancer, lymphoma, and lungs 
cancer
Taxus brevifolius (Taxaceae) Paciltaxel and Taxotere Ovarian, malignant melanoma, breast, 
lungs, and pancreatic cancers
Mappia foetida 
(Icacinaceae)
Camptothecin, Irinotecan, and 
Topotecan




Quinoline and Camptothecin Skin, lungs, and cervical cancer
Juniperus communis 
(Cupressaceae)
Teniposide and Etoposie Lung cancer and lymphocytic leukemia 
in children
Table 1. 
Few important medicinal plants used as modern drugs for cancer treatment.
Drug Basic investigation
Digoxin Digitalis leaves were being used in heart therapy in Europe during the eighteenth century
Emetine Brazilian Indians and several others South American tribes used roots and rhizomes of 
Cephaelis sp. to induce vomiting and cure dysentery
Codeine, 
morphine
Opium, the latex of Papaver somniferum used by ancient Sumerians. Egyptians and 
Greeks for the treatment of headaches, arthritis and inducing sleep
Ephedrine Crude drug (astringent yellow), derived from Ephedra sinica, had been used by Chinese 
for respiratory ailments since 2700 BC
Quinine Cinchona sp. were used by Peruvian Indians for the treatment of fevers
Colchicine Use of Colchicum in the treatment of gout has been known in Europe since 78 AD
Table 2. 
Plant-derived ethnotherapeutics and traditional modern medicine.
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